Neocytolysis: physiological down-regulator of red-cell mass
- PMID: 9149714
- DOI: 10.1016/S0140-6736(96)09208-2
Neocytolysis: physiological down-regulator of red-cell mass
Abstract
It is usually considered that red-cell mass is controlled by erythropoietin-driven bone marrow red-cell production, and no physiological mechanisms can shorten survival of circulating red cells. In adapting to acute plethora in microgravity, astronauts' red-cell mass falls too rapidly to be explained by diminished red-cell production. Ferrokinetics show no early decline in erythropolesis, but red cells radiolabelled 12 days before launch survive normally. Selective destruction of the youngest circulating red cells-a process we call neocytolysis-is the only plausible explanation. A fall in erythropoietin below a threshold is likely to initiate neocytolysis, probably by influencing surface-adhesion molecules. Recognition of neocytolysis will require re-examination of the pathophysiology and treatment of several blood disorders, including the anaemia of renal disease.
Similar articles
-
Modulation of red cell mass by neocytolysis in space and on Earth.Pflugers Arch. 2000;441(2-3 Suppl):R91-4. doi: 10.1007/s004240000333. Pflugers Arch. 2000. PMID: 11200988 Review.
-
Control of red blood cell mass in spaceflight.J Appl Physiol (1985). 1996 Jul;81(1):98-104. doi: 10.1152/jappl.1996.81.1.98. J Appl Physiol (1985). 1996. PMID: 8828651 Clinical Trial.
-
Anemia and erythropoietin in space flights.Semin Nephrol. 2005 Nov;25(6):379-87. doi: 10.1016/j.semnephrol.2005.05.006. Semin Nephrol. 2005. PMID: 16298259 Review.
-
[Research proceeding on the effect of microgravity on erythropoiesis].Space Med Med Eng (Beijing). 2001 Aug;14(4):298-302. Space Med Med Eng (Beijing). 2001. PMID: 11681347 Review. Chinese.
-
Erythropoietin withdrawal alters interactions between young red blood cells, splenic endothelial cells, and macrophages: an in vitro model of neocytolysis.J Investig Med. 2001 Jul;49(4):335-45. doi: 10.2310/6650.2001.33899. J Investig Med. 2001. PMID: 11478410
Cited by
-
Dosing of erythropoiesis-stimulating agents can be reduced by a new administration regimen.Nephron Extra. 2011 Jan;1(1):45-54. doi: 10.1159/000329889. Epub 2011 Aug 19. Nephron Extra. 2011. PMID: 22470378 Free PMC article.
-
No ergogenic effects of a 10-day combined heat and hypoxic acclimation on aerobic performance in normoxic thermoneutral or hot conditions.Eur J Appl Physiol. 2019 Dec;119(11-12):2513-2527. doi: 10.1007/s00421-019-04215-5. Epub 2019 Sep 25. Eur J Appl Physiol. 2019. PMID: 31555926 Clinical Trial.
-
Absence of polycythemia in a child with a unique erythropoietin receptor mutation in a family with autosomal dominant primary polycythemia.J Clin Invest. 1998 Jul 1;102(1):124-9. doi: 10.1172/JCI2886. J Clin Invest. 1998. PMID: 9649565 Free PMC article.
-
HIF-mediated increased ROS from reduced mitophagy and decreased catalase causes neocytolysis.J Mol Med (Berl). 2015 Aug;93(8):857-66. doi: 10.1007/s00109-015-1294-y. Epub 2015 May 28. J Mol Med (Berl). 2015. PMID: 26017143
-
Rapid weight loss and the body fluid balance and hemoglobin mass of elite amateur boxers.J Athl Train. 2013 Jan-Feb;48(1):109-17. doi: 10.4085/1062-6050-48.1.05. J Athl Train. 2013. PMID: 23672332 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous